Moreover, anti-miR-550a-3p had a smaller effect on cyclin D1 and c-myc in MDA-MB-231 cells, which have the lowest level of endogenous miR-550a-3p among the sampled breast cancer cell lines (Figure 1A). This evidence concerns the gene MYC and breast carcinoma.